Profile data is unavailable for this security.
About the company
Artrya Limited is a medical technology company. The Company is developing artificial intelligence (AI) powered solutions to improve the detection and management of coronary artery disease. It is an applied artificial intelligence healthcare company that works alongside clinicians to improve the diagnosis of coronary heart disease and develop an overview of a patient at risk. The company has developed deep learning algorithms that allow for the prediction and prevention of acute coronary events. Its Artrya Salix is a computed tomography coronary angiography (CCTA) image analysis solution that enables physicians with AI to identify and analyze the extent and type of arterial plaque. This solution uses no external reading teams to validate cardiac scan data, allowing physicians direct control of their AI-supported patient scans. Artrya Salix provides solutions for physicians and patients.
- Revenue in AUD (TTM)28.00k
- Net income in AUD-16.41m
- Incorporated2018
- Employees--
- LocationArtrya Ltd1257 Hay Street, West PerthPERTH 6005AustraliaAUS
- Phone+61 86478-7816
- Websitehttps://www.artrya.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apiam Animal Health Ltd | 206.92m | 832.00k | 145.62m | -- | 205.57 | 1.17 | 10.69 | 0.7037 | 0.0038 | 0.0038 | 1.11 | 0.6613 | 0.809 | 4.57 | 15.75 | -- | 0.3378 | 1.65 | 0.3896 | 1.93 | 66.22 | 63.46 | 0.4175 | 1.97 | 0.5026 | 2.33 | 0.4586 | 71.37 | 1.11 | 11.83 | -83.13 | -27.29 | 27.96 | 0.3129 |
| Eureka Group Holdings Ltd | 45.79m | 20.06m | 200.49m | 42.00 | 9.28 | 0.8297 | 9.76 | 4.38 | 0.0506 | 0.0506 | 0.1189 | 0.5664 | 0.1506 | -- | 206.26 | -- | 6.60 | 6.12 | 6.75 | 6.29 | 54.76 | 52.75 | 43.81 | 37.02 | -- | -- | 0.1908 | 30.22 | 11.30 | 13.04 | 51.90 | 19.90 | 21.25 | 6.71 |
| Monash IVF Group Ltd | 271.92m | 25.01m | 272.74m | 892.00 | 10.97 | 1.11 | 5.72 | 1.00 | 0.0638 | 0.0638 | 0.6947 | 0.6321 | 0.5433 | 3.43 | 9.15 | 304,839.70 | 5.13 | 4.12 | 6.32 | 4.84 | 89.16 | 89.42 | 9.44 | 7.69 | 0.5321 | 6.08 | 0.4182 | 95.49 | 6.65 | 13.34 | 483.15 | 16.36 | 13.96 | 5.80 |
| Australian Clinical Labs Ltd | 741.27m | 32.43m | 465.17m | 4.70k | 13.91 | 2.75 | 2.75 | 0.6275 | 0.174 | 0.174 | 3.90 | 0.8812 | 1.27 | 7.90 | 10.16 | 157,716.80 | 5.62 | 12.05 | 8.84 | 18.53 | 82.70 | 81.44 | 4.43 | 8.79 | 0.4826 | 4.88 | 0.628 | 55.61 | 6.45 | 8.61 | 35.50 | -4.70 | -2.16 | -- |
| Artrya Ltd | 28.00k | -16.41m | 490.06m | -- | -- | 16.51 | -- | 17,502.16 | -0.1782 | -0.1782 | 0.0003 | 0.1878 | 0.0013 | -- | 0.006 | -- | -76.86 | -50.54 | -84.04 | -53.79 | -- | -- | -58,592.86 | -224,202.80 | -- | -- | 0.0285 | -- | -- | -- | -17.19 | -- | 76.21 | -- |
| Healius Ltd | 1.34bn | -563.00m | 562.75m | 8.00k | -- | 0.9572 | -- | 0.4187 | -0.7754 | -0.2082 | 1.85 | 0.8096 | 0.5648 | 6.94 | 7.21 | 168,025.00 | -23.66 | -7.07 | -30.32 | -8.67 | 84.08 | 85.70 | -41.88 | -14.73 | 0.4978 | 0.0031 | 0.608 | -- | 5.69 | -2.90 | 15.97 | -- | -7.13 | -- |
| Australian Unity Ltd | 2.56bn | 29.28m | 577.79m | 7.70k | -- | -- | 5.65 | 0.2256 | -- | -- | -- | -- | 0.2504 | -- | -- | -- | 0.2863 | 0.2535 | -- | -- | -- | -- | 1.14 | 1.08 | -- | 2.32 | 0.3517 | -- | 19.22 | 12.82 | 225.85 | 26.26 | -3.12 | -- |
| Integral Diagnostics Ltd | 627.22m | 4.67m | 895.02m | 3.03k | 200.17 | 1.29 | 14.59 | 1.43 | 0.012 | 0.012 | 2.02 | 1.86 | 0.5779 | 13.49 | 23.69 | 207,343.80 | 0.444 | 0.3746 | 0.4959 | 0.4202 | 95.52 | 95.19 | 0.7683 | 0.668 | 0.6595 | 2.13 | 0.4574 | 568.89 | 33.70 | 17.91 | 107.70 | -27.31 | 18.22 | -7.07 |
| Regis Healthcare Ltd | 1.16bn | 48.95m | 1.88bn | 11.00k | 38.55 | -- | 19.01 | 1.62 | 0.1611 | 0.1611 | 3.82 | -0.0555 | 0.5928 | -- | 46.38 | -- | 2.50 | -0.2222 | -- | -2.22 | -- | -- | 4.22 | -0.4523 | -- | -- | -- | -- | 14.52 | 11.37 | 328.58 | -- | 17.09 | 32.18 |
| Holder | Shares | % Held |
|---|---|---|
| Regal Funds Management Pty Ltd.as of 02 Dec 2025 | 15.85m | 10.03% |
| Wilson Asset Management (International) Pty Ltd.as of 29 Jan 2026 | 10.63m | 6.72% |
| Paradice Investment Management Pty Ltd.as of 29 Jan 2026 | 7.89m | 4.99% |
| Pengana Capital Ltd.as of 31 Oct 2025 | 6.37m | 4.03% |
| Netwealth Investments Ltd.as of 30 Sep 2025 | 3.54m | 2.24% |
| Mutual Trust Pty Ltd.as of 30 Sep 2025 | 3.16m | 2.00% |
| BetaShares Capital Ltd.as of 30 Jan 2026 | 503.56k | 0.32% |
| Antares Capital Partners Ltd.as of 30 Nov 2025 | 289.61k | 0.18% |
